AXDX on NASDAQ

Accelerate Diagnostics

Diagnostics company.1

Price unavailable

Last updated Oct 16, 2026.

Overview

1987Founded1

Compare with Lifeloc Technologies, Inc, Seer, Inc or Precipio, Inc., or pick any stock.

  • TickerAXDX on NASDAQ1
  • IndustryLaboratory Analytical Instruments1
  • HeadquartersTucson1
  • Websiteacceleratediagnostics.com
  • Legal formDelaware corporation1
  • Incorporated inDE3
  • Business address3950 S. Country Club Road #470, Building 3-307, Tucson, Az 857143
  • Filer categoryNon-accelerated filer, Smaller reporting company3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

23.1%Gross margin4
-301.8%Operating margin4
-427.8%Net margin4
-3.0%Revenue growth, 20244

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Cost of revenue19¢$9.0M
  • Research and development35¢$16.7M
  • Selling, general and admin45¢$21.3M
  • Income tax0¢$66.0K

Out of $11.7M in revenue.4 The company lost money this year.

Financial statements

Revenue56784$11.7M in 2024+106% since 2018
0$5.0M$10.0M$15.0M2018: $5.7M$5.7M20182019: $9.3M$9.3M2019+64%2020: $11.2M$11.2M2020+20%2021: $11.8M$11.8M2021+6%2022: $12.8M$12.8M2022+8%2023: $12.1M$12.1M2023−5%2024: $11.7M$11.7M2024−3%
Gross profit56784$2.7M in 2024+9% since 2018
-$2.0M0$2.0M$4.0M$6.0M2018: $2.5M$2.5M20182019: $4.4M$4.4M2019+77%2020: $4.5M$4.5M2020+1%2021: -$381.0K-$381.0K20212022: $3.3M$3.3M20222023: $2.5M$2.5M2023−23%2024: $2.7M$2.7M2024+6%
Operating income56784-$35.3M in 2024−56% since 2018
-$100.0M-$75.0M-$50.0M-$25.0M02018: -$80.4M-$80.4M20182019: -$72.8M-$72.8M2019−9%2020: -$63.7M-$63.7M2020−13%2021: -$71.6M-$71.6M2021+12%2022: -$62.8M-$62.8M2022−12%2023: -$54.0M-$54.0M2023−14%2024: -$35.3M-$35.3M2024−35%
Net income56784-$50.0M in 2024−43% since 2018
-$100.0M-$75.0M-$50.0M-$25.0M02018: -$88.3M-$88.3M20182019: -$84.3M-$84.3M2019−5%2020: -$78.2M-$78.2M2020−7%2021: -$77.7M-$77.7M2021−1%2022: -$62.5M-$62.5M2022−20%2023: -$61.6M-$61.6M2023−1%2024: -$50.0M-$50.0M2024−19%
Fiscal year2018201920202021202220232024
Revenue$5.7M5$9.3M6$11.2M7$11.8M8$12.8M8$12.1M4$11.7M4
Cost of revenue$3.2M5$4.9M6$6.7M7$12.2M8$9.4M8$9.5M4$9.0M4
Gross profit$2.5M5$4.4M6$4.5M7-$381.0K8$3.3M8$2.5M4$2.7M4
Research and development$27.6M5$25.3M6$21.3M7$21.9M8$26.9M8$25.4M4$16.7M4
Selling, general and admin$55.2M5$51.9M6$46.9M7$49.2M8$39.2M8$31.2M4$21.3M4
Operating income-$80.4M5-$72.8M6-$63.7M7-$71.6M8-$62.8M8-$54.0M4-$35.3M4
Interest$14.3M6$15.6M6$15.5M6
Income tax$211.0K5-$111.0K6$5.0K7$45.0K8-$77.0K8$850.0K4-$66.0K4
Net income-$88.3M5-$84.3M6-$78.2M7-$77.7M8-$62.5M8-$61.6M4-$50.0M4
Earnings per share-$1.556-$1.407-$12.598-$7.618-$4.944-$2.154
Earnings per share (diluted)-$1.556-$1.407-$12.598-$7.618-$4.944-$2.154

Compare Accelerate Diagnostics with another company

Employees over time

  • 20192751

Former names

  • ACCELR8 TECHNOLOGY CORPDec 15, 1995 to Dec 26, 20123

Timeline

  1. Dec 26, 2012Went public Listed on NASDAQ1
  2. 1987Founded Founded1

Recent filings

  1. Aug 18, 20258-K
  2. Jun 25, 20253 OWNERSHIP DOCUMENT
  3. Jun 4, 20258-K
  4. May 28, 20258-K
  5. May 12, 20258-K
  6. May 8, 20258-K
  7. May 1, 20253 OWNERSHIP DOCUMENT
  8. Apr 30, 202510-K/A
  9. Apr 25, 20258-K
  10. Apr 15, 20258-K
  11. Apr 7, 20254 OWNERSHIP DOCUMENT
  12. Apr 7, 20254 OWNERSHIP DOCUMENT
  13. Apr 2, 20254 OWNERSHIP DOCUMENT
  14. Mar 21, 202510-K
  15. Mar 21, 20258-K

Every filing from the last three years, summarized. The full record is on SEC EDGAR.2

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12